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Abstract
INTRODUCTION: The continued rise in the prevalence of adult obesity in the United States is
a public health concern. Several studies have identified the increasing rates of obesity, its
impacts, and the factors leading to obesity. Some researchers have made obesity prevalence
projections at the national and state levels. This study aims to fill the critical gap in real-time
weight data trends among primary care adult patients in Nebraska. The main goal of this study is
to determine and analyze the weight trajectory of adults in Nebraska over the past five years and
determine if the trends vary among age and gender and if the COVID-19 pandemic impacted
weight trajectory. Additionally, this study will compare the collected data to the national obesity
prevalence and other researchers’ obesity prevalence projections at the national and state level.
METHODS: A retrospective cohort study using un-identified data extracted from Nebraska
Medicine’s electronic health record sub-database was utilized to examine adult obesity
prevalence based on weights and heights recorded during medical encounters. A sample of
16,507 adults had data recorded for 390,789 unique encounters. The study utilized simple
descriptive statistics to calculate frequencies/percentages and means/standard deviations to
determine the current prevalence of adult obesity in Nebraska to compare to the national
prevalence and other researchers’ prevalence predictions.
RESULTS: The average BMI of the study sample (n=16,507) was 30.6 (SD=7.1). The current
obesity prevalence among our study sample is 47.6% for overall obesity (BMI  30) and 24.0%
for severe obesity (BMI  35). The overall obesity prevalence is 47.9% among females and
47.1% among males. The prevalence of severe obesity is 26.8% among females and 19.9%
among males. From January 2017 to October 2021, the average BMI among females and males
increased among individuals aged 20 to 49, with females experiencing a larger increase in BMI.
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Weight loss occurred among both females and males aged 50 years and older. Individuals aged
40-49 years had the highest BMI among females and males.
CONCLUSION: This study provides real-time weight trend data among the Nebraska adult
population, including the current prevalence of overall and severe obesity. The obesity
prevalence in Nebraska continues to move further away from the Healthy People 2030 goal of
36.0% and is close to reaching and exceeding 2030 obesity prevalence research projections,
highlighting the importance and critical need for public health interventions to reduce obesity
among adults in Nebraska.
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Introduction
The rising prevalence of overweight and obese adults in the United States is a public
health concern. Despite the Healthy People 2030 objective of reducing obesity (Overweight and
Obesity- Healthy People 2030, n.d.), the prevalence of obesity continues to rise year after year.
In 2018, the age-adjusted prevalence of obesity among U.S. adults was 42.4% (Hales et al.,
2020), and by 2030, 81.0% of adult males and 74.9% of adult females are projected to be
overweight or obese (Wang et al., 2020). These projections are alarming and would result in a
doubling of obesity rates in just 12 years. In Nebraska, the self-reported obesity prevalence was
34.0% in 2020 (New Adult Obesity Maps, 2021). Based on data gathered for a national health
population survey, weight gain among the Nebraska adult population is projected to reach an
obesity prevalence of greater than 50% by 2030 (Ward et al., 2019).
Obesity is a health disease defined by having an excess amount of body fat and is
classified in terms of Body Mass Index (BMI), which measures weight related to height.
Overweight is defined as having a BMI from 25.0 to 29.9 kg/ m2, and obesity is defined as
having a BMI  30.0 kg/m2. Further, obesity is subdivided into classes, where class 1 is a BMI of
30-34.9 kg/m2, class 2 is a BMI of 35-39.9 kg/m2, and class 3 is a BMI of  40.0 kg/m2 (CDC,
2021).
Obesity is a multi-factorial disease process, and there is not one exact cause of obesity.
Obesity has been linked to various factors, including biologic, psychosocial, and behavioral,
including genetic makeup, socioeconomic status, and cultural influences (Apovian, 2020).
Further, the rising prevalence of obesity is largely related to lifestyle behaviors, such as physical
activity, inactivity, dietary patterns, medication use, and other exposures. Additional factors
impacting the rising rates of obesity may include an individual’s physical environment,

5

education, skills, and food marketing and promotion (Dombrowski et al., 2012; Adult Obesity
Causes & Consequences, 2021).
Keeping in mind that behaviors such as regular physical activity and healthy eating are
vital in preventing and reducing obesity rates, researchers have begun to investigate the impact
of the COVID-19 pandemic on weight gain and obesity (Lin et al., 2021). On March 11, 2020,
the World Health Organization declared COVID-19 a global pandemic. To curb the spread of the
disease, many states and cities issued stay-at-home orders and quarantine recommendations. It is
known that social distancing measures implemented during the COVID-19 pandemic led to
significant changes in many Americans’ lifestyles (Lin et al., 2021). Such social distancing
measures lead to changed eating habits, high levels of stress and fear, and decreased physical
activity due to the closure of schools, gyms, and parks and people working from home (Aghili et
al., 2021). Although few studies have thoroughly investigated the impact that COVID-19 had on
weight and weight-related behaviors, it is thought that the effects may be substantial (Lin et al.,
2021).
As the prevalence of obesity rises, so do the physical, mental, and social impacts
experienced from obesity. Obesity is known to be a significant risk factor for morbidity and
mortality from multiple diseases such as type 2 diabetes, hypertension, coronary heart disease,
cerebrovascular disease, stroke, osteoarthritis, chronic musculoskeletal pain, and many types of
cancer (Perreault & Laferrere, 2020; Li et al., 2015; Guh et al., 2009; Engin, 2017; Seravalle &
Grassi, 2017; Mitchell et al., 2015; Oliveria et al., 2020; De Pergola & Silvestris, 2013). Some of
the comorbidities mentioned are the top leading causes of death in the U.S. and worldwide,
including diabetes, heart disease, stroke, and some types of cancer, highlighting the importance
of reducing obesity rates (Adult Obesity Causes & Consequences, 2021). In addition to the
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physical comorbidities associated with obesity, obesity has mental health impacts such as
depression, low self-esteem, mood disorders, discrimination, and social bias (Avila et al., 2015;
Taylor et al., 2013). Overall, the physical, mental, and social impacts of obesity lead to a
decreased quality of life due to reduced overall functional capacity (Taylor et al., 2013). One
study found that individuals with severe obesity spent most of their time participating in daily
living activities and less time in work and recreational activities when compared to the non-obese
population (Forhan et al., 2011). Decreased participation in such activities leads to an increased
risk for mental health disorders such as depression, leading to decreased nutritional intake and
physical activity, ultimately compounding multiple negative impacts of obesity (Taylor et al.,
2013).
The increase in the prevalence of obesity has and will continue to have significant cost
implications for the healthcare system, and there is a consensus among researchers that as BMI
rises, so too does the direct healthcare costs and indirect costs (Dee et al., 2014; Adult Obesity
Causes & Consequences, 2021). Direct medical costs may include preventive, diagnostic, and
treatment services. In contrast, indirect costs relate to sickness and death and include lost
productivity, such as being absent from work, decreased productivity while at work, disability,
and premature death (Adult Obesity Causes & Consequences, 2021). The estimated annual
medical cost of obesity in the U.S. was $147 billion in 2008, and the medical cost for obese
individuals was $1,429 higher than those of normal weight (Hales et al., 2020). Other researchers
report that annual spending related to obesity and its associated comorbidities was estimated at
$315.8 billion in 2010, accounting for 27.5% of U.S. healthcare expenditures (Cawley et al.,
2015). Additionally, costs related to being overweight or obese are projected to reach $861
billion in 2030 (Wang et al., 2008). As of 2010, overweight and obesity were estimated to cause
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3.4 million deaths, 4% years of life lost, and 4% of disability-adjusted life-years (DALYs)
worldwide (Ng et al., 2014).
Several studies have identified the increasing rates of obesity, its impacts, and the factors
leading to obesity. Although some studies have even made obesity prevalence projections on the
national and state level (Ward et al., 2019 & Wang et al., 2020), no study to our knowledge has
collected and analyzed real-time population weight data within the Nebraska population. Our
study intends to fill the critical gap in real-time weight data trends among primary care adult
patients in Nebraska. Additionally, this study intends to collect and analyze Nebraska-specific
weight data during the COVID-19 pandemic and discuss potential weight trends associated with
the COVID-19 pandemic. We anticipate that our findings will be utilized to educate the public
and healthcare providers on the current state of obesity and recent weight trends among the
Nebraska adult population. Further, our research findings will provide healthcare providers and
educators with real-time data to base obesity reduction and prevention strategies, programs, and
interventions.
This research study aims to determine and analyze the weight trajectory of non-pregnant
adults in Nebraska over the past five years and weight changes during the COVID-19 pandemic.
Secondly, we will examine the collected data to determine if weight trends vary among age
and/or gender. Third, this research study will compare the collected data to the national obesity
prevalence and compare the data to researchers’ obesity projections at the national and state level
(Ward et al., 2019 & Wang et al., 2020). We aim to answer the following research questions:
1. Has weight gain occurred over the past five years within the Nebraska adult population?
2. Was there a significant change in weight during the COVID-19 pandemic among the
Nebraska adult population?
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3. Do the weight trends in the past five years vary by age and or gender?
4. How do the weight trends in the past five years compare to the current national obesity
prevalence other researchers’ obesity prevalence projections on the national and state
level (Hales et al., 2020 & Ward et al., 2019)?

Methods
We conducted a retrospective cohort study using Nebraska Medicine electronic health
record data extracted from EPIC. Living, non-pregnant adults aged 19 years and above were
included if they had at least two weight measurements recorded in their electronic medical record
between January 1, 2017, and October 31, 2021, with one weight measurement being taken in
January 2017, and were a patient seen at a Nebraska Medicine family medicine clinic. The
sample size for this study was 16,507, with 390,789 unique encounters. Demographics for each
patient were also extracted from the Nebraska Medicine electronic health record, including age,
gender, ethnicity, race, and COVID-19 diagnosis during the study time. Participant age was
grouped into 20 to 29 years, 30 to 39 years, 40 to 49 years, 50 to 59 years, 60 to 69 years, 70 to
79 years, and 80 years and older. For those patients with missing heights in their medical
records, we used the average height for females or males. Additionally, some patients had
multiple weight measurements recorded on the same day, of which we took an average of those
heights.
The extracted data were analyzed using simple descriptive statistics, where we calculated
the frequencies and percentages of the patient demographics and prevalence of adult obesity for
overall, females, and males. Average BMI was calculated for each age group for both females
and males. The data was extracted from a de-identified sub-database from EPIC, UNMC’s
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Clinical Research Analytics Environment (CRANE), removing all PHI identifiers. The study did
not restrict race or ethnic origin and did not include any vulnerable subjects. The research data
was stored securely on UNMC’s OneDrive for Business.

Results
A total of 390,789 weight measurements from 16,507 unique individuals were extracted
from Nebraska Medicine EPIC sub-database, with a mean of 23 weight measurements per
individual. Of the 16,507 individuals with a mean age of 54.3 years (SD = 17.1), 9,852 (59.7%)
were female and 6,653 (40.3%) were male. The average BMI was 30.6 (SD = 7.1). Demographic
characteristics of the study sample are presented in Table 1. The study sample was 59.7% female
and 40.3% male. Adults aged 20 to 29 years of age made up 9.4% of the sample, 12.1% were 30
to 39 years of age, 15.1% were 40 to 49 years of age, 21.1% were 50 to 59 years of age, 22.0%
were 60 to 69 years of age, 13.2% were 70 to 79 years of age, and 6.4% were 80 years of age or
older. The majority of the sample was White (80.9%), followed by Black or African American
(12.4%). Other races made up 3.2% of the sample, while 3.4% of the sample’s race was
unknown. The majority of the sample was non-Hispanic (95.6%), and 7.1% of the sample had a
COVID-19 diagnosis documented in their EHR during the study period.
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Table 1. Demographic characteristics of Study Sample (n=16,507)

Variable

Characteristics

Age

20-29
30-39
40-49
50-59
60-69
70-79
80+
Female
Male
American Indian or Alaska
Native
Asian
Black or African American
Native Hawaiian or Other
Pacific Islander
White
Multi-race
Unknowna
Hispanic or Latino
Not Hispanic or Latino
Unknown*
Yes
No

Sex
Race

Ethnicity

COVID-19
diagnosisb
a
b

Frequency
(n=16,507)
1550
1996
2491
3488
3637
2176
1051
9852
6653
98

Percent

232
2039
40

1.4
12.4
0.2

13361
171
566
678
15782
47
1165
15342

80.9
1.0
3.4
4.1
95.6
0.3
7.1
92.9

9.4
12.1
15.1
21.1
22.0
13.2
6.4
59.7
40.3
0.6

Unknown = designation for patients who did not have demographic data available in their chart
COVID-19 diagnosis recorded in patient’s chart anytime throughout the study period

The current obesity prevalence among our study sample is 47.6% for overall obesity
(BMI  30) and 24.0% for severe obesity (BMI  35). The overall obesity (BMI  30) prevalence
is 47.9% among females and 47.1% among males. The severe obesity (BMI  35) prevalence is
26.8% among females and 19.9% among males. These findings are presented in Table 2. Figures
1 and 2 demonstrate the prevalence of overweight and obesity of females and males by age group
throughout the study period.
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Table 2. Prevalence of Adult Obesity and Severe Obesity in October 2021
Obesity Class

Sex

Percentage (95% CI)

Overall Obesity
(BMI,  30)

Overall

47.6
(46.8-48.3)
47.9
(46.9-48.9)
47.1
(45.9-48.3)
24.0
(23.4-24.7)
26.8
(25.9-27.7)
19.9
(19.0-20.9)

Female
Male
Severe Obesity
(BMI,  35)

Overall
Female
Male

Figure 1. Percentage of females classified as overweight or obese by age group from January
2017-October 2021.

Prevalence of Overweight or Obese,
by Age, Females
100%
90%
80%
20-29

70%

30-39

60%
50%

40-49

40%

50-59

30%

60-69

20%

70-79

10%

80+

12

Oct-21

Jul-21

Apr-21

Jan-21

Oct-20

Jul-20

Apr-20

Jan-20

Oct-19

Jul-19

Apr-19

Jan-19

Oct-18

Jul-18

Apr-18

Jan-18

Oct-17

Jul-17

Apr-17

Jan-17

0%

Figure 2. Percentage of males classified as overweight or obese by age group from January
2017-October 2021.
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by Age, Males
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Table 3 further displays the weight changes that occurred throughout the 5-year study
period by age for females and males. From January 2017 to October 2021, the average BMI
among females increased among the following age groups: 20-29 by 1.24%, 30-39 by 0.65%,
and 40-49 by 0.41%. The average BMI among females decreased among the following age
groups: 50-59 by 0.14%, 60-69 by 0.36%, 70-79 by 0.83%, and 80+ by 0.95%. From January
2017 to October 2021, the average BMI among males increased among the following age
groups: 20-29 by 0.68%, 30-39 by 0.21%, and 40-49% by 0.09%. Figures 3 and 4 display the
average BMI among females and males by age group throughout the study period.
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Table 3. Weight Changes in Adults Over five years, January 2017 – October 2021
Sex

Age group

Start

Average BMI for age, mean (SD)
Female
20-29
28.24 (7.17)

Male

End

Change
(95% CI)

Number of
weeks
between first
and last visit,
mean (SD)

29.48 (7.60)

1.24
(1.03 to 1.46)
0.65
(0.43 to 0.86)
0.41
(0.22 to 0.60)
-0.14
(-0.30 to 0.02)
-0.36
(-0.50 to -0.21)
-0.83
(-1.01 to -0.66)
-0.95
(-1.17 to -0.73)
0.68
(0.44 to 0.92)
0.21
(-0.01 to 0.43)
0.09
(-0.10 to 0.27)
-0.05
(-0.22 to 0.12)
-0.57
(-0.72 to -0.42)
-0.89
(-1.07 to -0.71)
-0.94
(-1.18 to -0.69)

170 (82)

30-39

31.49 (8.36)

32.14 (8.44)

40-49

32.03 (8.36)

32.44 (8.36)

50-59

31.87 (7.75)

31.74 (7.84)

60-69

31.32 (7.51)

30.96 (7.55)

70-79

29.85 (6.58)

29.02 (6.53)

80+

27.62 (5.77)

26.67 (5.61)

20-29

28.09 (6.46)

28.77 (6.54)

30-39

30.52 (6.75)

30.73 (6.90)

40-49

31.63 (6.48)

31.71 (6.61)

50-59

31.02 (6.21)

30.97 (6.49)

60-69

30.74 (5.88)

30.17 (6.06)

70-79

29.91 (5.28)

29.02 (5.34)

80+

27.87 (4.74)

26.94 (4.80)
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184 (80)
197 (73)
203 (70)
204 (71)
202 (72)
169 (82)
164 (82)
177 (80)
188 (77)
202 (70)
203 (71)
196 (76)
154 (88)

Figure 3. Average BMI among females by age group from January 2017 - October 2021.

Average BMI by Age, Females
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Figure 4. Average BMI among males by age group from January 2017 - October 2021.

Average BMI by Age, Males
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Discussion
This study aimed to determine and analyze the weight trajectory of adults in Nebraska
over the past five years and determine if the trends vary among age and gender and if the
COVID-19 pandemic impacted weight trajectory. Further, this study aimed to compare the
collected data to the national obesity prevalence and other researchers’ obesity prevalence
projections at the national and state level. Within the Nebraska adult population, the average
BMI was 30.6, which is classified as obese (BMI  30). Overall, 47.6% of our study sample was
obese (BMI  30) and 24.0% were severely obese (BMI  35). The prevalence of obesity among
our sample (47.6%) was significantly higher than the Nebraska self-reported obesity prevalence
of 34.0% in 2020 (New Adult Obesity Maps, 2021).
The results of this study revealed that the prevalence of overall obesity and severe obesity
was greater among females (47.9% and 26.8%, respectively) than males (47.1% and 19.9%,
respectively), which is consistent with previous studies that have found a higher prevalence of
obesity among females than males (CDC, 2017; Wang et al., 2020; Hales et al., 2018; & Hales et
al., 2020). From January 2017 to October 2021, the average BMI for both females and males
increased among individuals aged 20-49 years, while it decreased among individuals aged 50
years and older. These results differ from a previous study, which found that adults aged 40-59
had the highest prevalence of obesity and severe obesity (Hales et al., 2020). This age group
dichotomy among adults aged 40 to 49 years and 50 to 59 years highlights an important area of
focus for future studies. This study also revealed that the average BMI for females increased
higher among females than for males aged 20-49 years.
Among both females and males, those aged 20 to 29 saw the largest percentage increase
in BMI (1.24% and 0.68%, respectively), which is not typically noted by other obesity trend
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studies (Hales et al., 2018 & Hales et al., 2020). This age group is younger and normally more
active, and these larger percentage increases in BMI may be due to changes in lifestyles due to
COVID-19 impacts (Lin et al., 2021 & Aghili et al., 2021). Though, when looking at the
COVID-19 pandemic that overlapped with the study timeframe (March 2020 to October 2021),
no significant change was noted in the average BMI and weight trends among each age group
during the COVID-19 pandemic timeframe for both females and males. The lack of anticipated
impact on weight gain may be related to Nebraska not having issued “stay-at-home” orders and
only providing quarantine and social distancing recommendations. Further, the current study did
not follow weight trends beyond October 2021, and the impacts of the COVID-19 pandemic are
still ongoing currently (May 2022). Future studies will be needed to identify better and analyze
the effects of COVID-19 on weight trajectory.
Table 4 summarizes our study findings compared to the 2030 projections of Ward et al.
(2019). As noted in the table, the prevalence of obesity in Nebraska continues to increase toward
both the Nebraska projections and the United States overall projections. Though Nebraska has
not yet surpassed these 2030 projections, Nebraska adults are incredibly close to their
projections, especially for the prevalence of severe obesity. Based on the current study results, it
would not be surprising if the overall obesity and severe obesity prevalence among Nebraska
adults exceed the Ward et al. (2019) 2030 projections by or before 2030.
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Table 4. Prevalence of Adult Obesity and Severe Obesity in October 2021, compared to Ward et
al., 2019 2030 projections
Our Study

Overall Obesity
(BMI,  30)

Overall
Female
Male

Severe Obesity
(BMI,  35)

Overall
Female
Male

Ward et al., 2019 Ward et al., 2019
2030 projections, 2030 projections,
Nebraska*
U.S. Overall*

Percentage (95% CI)
47.6
(46.8-48.3)
47.9
(46.9-48.9)
47.1
(45.9-48.3)
24.0
(23.4-24.7)
26.8
(25.9-27.7)
19.9
(19.0-20.9)

51.3
(49.3-53.3)
51.7
(49.2-54.1)
51.0
(48.3-53.7)
25.4
(23.4-27.4)
29.6
(27.0-32.2)
21.5
(18.9-24.1)

48.9
(47.7-50.1)
49.9
(48.5-51.4)
48.2
(46.8-49.6)
24.2
(22.9-25.5)
27.6
(26.1-29.2)
21.1
(19.6-22.6)

Limitations of the present study are necessary to consider when interpreting the results.
Several influences may help to explain the differences noted in adult obesity prevalence, causing
the variances mentioned in age and gender for this study. Among the possible influences not
identified in the current study are the impacts of medication use, weight gain, mid-life crisis
weight gain, and lifestyle behaviors varying among age groups and gender, which would benefit
from future studies further analyzing the impacts. Although the data for this study was extracted
from the patient’s EHR, we cannot ensure that all the weight and height data were objectively
measured, and the heights and weights were not measured using standardized techniques and/or
equipment. If medical providers had asked patients for self-reported weight and height
measurements, the data might be subject to bias.
Another limitation of this study is that the encounter number varied by patient and obese
individuals are likely to have more medical encounters, which could have skewed our data set.
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Further, the study only included individuals with in-person appointments, which may have been
impacted by healthy individuals not seeking routine medical visits during the COVID-19
pandemic. Another limitation of the current study is that we compared our Urban data to Ward et
al. (2019) statewide projections. When comparing our results of the obesity prevalence in
Nebraska to that of the obesity prevalence on a national level, we need to consider further the
regional disparities of obesity prevalence in the U.S., in which obesity prevalence is highest in
the South (32.0%) and the Midwest (31.4%) (Myers et al., 2014 & Wang et al., 2019), which
would also benefit from future studies.
Despite these limitations, this study provides essential information on the current
prevalence of obesity in Nebraska and insight into variances in obesity prevalence by age and
gender. This analysis utilized a large sample (n=16,507) of subjects, with 20% of the sample
being of minority ethnicity. Both further support the generalizability of our findings to the
Nebraska adult population. The EHR data extracted for this study presents a significant
opportunity for future research. This data set can be further utilized to analyze obesity prevalence
by race and ethnicity, as this was not analyzed for the current study. This study also provides
insight and direction for future public health interventions or policy change at the local and state
level. The data utilized in this study will allow for future public health research, and the results
may allow for in-practice identification and implementation of strategies, programs, and
interventions to mitigate and minimize weight gain among adults in Nebraska. Specifically, this
study identifies which age groups and gender should be targeted for such programs and
interventions to reduce Nebraska's weight gain and obesity rates effectively. Further, the current
study results can inform current practices among primary care providers, educators, and
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stakeholders interested in reducing obesity and the increased health risks associated with obesity
in Nebraska.
Conclusion
Overall, the obesity prevalence in Nebraska continues to move further away from the
Healthy People 2030 goal of 36.0% (Overweight and Obesity- Healthy People 2030, n.d. This
study found that the average BMI has increased among females and males aged 20 to 49, with
the highest percentage increase among those aged 20 to 29, and the average BMI decreased
among females and males aged 50 and older in Nebraska. Further, we found that the prevalence
of obesity is higher among females than males for both overall obesity and severe obesity. We
did not observe weight trajectory differences during the COVID-19 pandemic within the study
period. Overall, Nebraska is close to reaching and exceeding 2030 obesity prevalence
projections, highlighting the importance and critical need for public health interventions to
reduce obesity among adults in Nebraska.
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